Giant omphaloceles (GO) frequently present challenges to closure that are often influenced by patient factors, including degree of visceroabdominal disproportion, associated comorbidities (including pulmonary hypoplasia), and variation in surgeon ...
Zach Z. Zhang +4 more
doaj +1 more source
Umbilical cord sparing technique of umbilicoplasty in infants with giant omphalocele. [PDF]
Wang P, Tou J.
europepmc +1 more source
Associated anomalies and clinical outcomes in infants with omphalocele: A single-centre 10-year review [PDF]
Objective: To examine the perinatal characteristics, associated anomalies and clinical outcomes of newborns with omphalocele admitted to Queen Mary Hospital (QMH), Hong Kong during a 10-year period.
Chee, WYY +5 more
core
Successful Administration of Preoperative Botox for Giant Omphalocele Repair With Ultrasound Guidance. [PDF]
Armijo AJ +8 more
europepmc +1 more source
Giant Omphalocele: 23 Patients; Three Different Approaches
Objective: Omphalocele is the ventral body wall maldevelopment. Early surgical interventions in the treatment of giant omphaloceles (GO) can increase morbidity and mortality. In this study, it was aimed to compare the advantages and disadvantages of primary closure, silo and vacuum assisted closure (VAC) methods used in omphalocele treatment. Materials
openaire +3 more sources
Giant omphalocele: A novel approach for primary repair in the neonatal period using botulinum toxin. [PDF]
Rombaldi MC +10 more
europepmc +1 more source
Delayed Closure of Giant Omphaloceles in West Africa: Report of Five Cases
Giant omphalocele (GO) management is controversial and not easy. Conservative management at birth and delayed surgical closure is usually mandatory. Postponed surgery may be challenging and carry the risk of intensive care treatment.
Oumama El Ezzi +4 more
doaj +1 more source
Systemic Inflammation Is Associated with Pulmonary Hypertension in Isolated Giant Omphalocele: A Population-Based Study. [PDF]
Teillet B +8 more
europepmc +1 more source
Using acellular porcine dermal matrix (XCM Biologic® Tissue Matrix) to repair a giant omphalocele: A case report. [PDF]
Park JY, Chung JH.
europepmc +1 more source

